Imigran Subject, known generically as sumatriptan, is a medication primarily used for the treatment of migraine headaches. It belongs to a class of drugs known as triptans, which work by narrowing blood vessels around the brain and reducing substances in the body that can trigger headache pain, nausea, sensitivity to light and sound, and other migraine symptoms. Imigran Subject is specifically designed for self-administration, providing rapid relief from migraine attacks. It is most effective when taken at the first sign of a migraine headache, but it is not intended for the prophylactic treatment of migraine or for the management of cluster headaches. The medication is available in various forms, including tablets, nasal sprays, and injections, allowing for flexibility in administration based on individual needs and preferences.